MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

Dec 10 2019

• By Ashley Yeo

Listen to this article

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.

Top 100

The top 100 publicly listed and reportable medical technology companies had global sales spanning from more than $30bn to some $100m in the lower reaches, according to the most recent year of fully reported results. As Medtech Insight's sales ranking for the 2018/2018-19 financial year shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.

It would be surprising not to say disquieting if, in mature industry sectors, the complexion and composition of the leading...

More from International

Global Medtech Guidance Tracker: September 2024
Oct 03 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.
Global Medtech Guidance Tracker: September 2024
Oct 02 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.
Global Medtech Guidance Tracker: August 2024
Sep 03 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Nearly 80 documents have been posted on the tracker since its last update.
Trunzo: ’We’ve Come A Long Way To Get To Regulatory Reliance’
Jul 23 2024
• By Ashley Yeo
Medical device regulatory reliance and recognition of third-party regulators’ approvals have been making news in the UK, but in certain other markets the practice is well established. International regulatory experts explained their experiences at the MedTech Forum 2024.

More from Geography

Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances
Sep 25 2024
• By Brian Bossetta
The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.
Biocomposites Fully Acquires SYNICEM And Subiton Lines, Launches NanoBone In UK
Sep 18 2024
• By Natasha Barrow
UK-based Biocomposites will begin selling in the UK its next-generation osteoinductive bone graft substitute, NanoBone, which came with its acquisition of Artoss GmbH in June 2023. Meanwhile, the company has purchased remaining shares in the manufacturers of SYNICEM and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers.
Senseonics Readies For US Launch Of 'World’s First One-Year CGM'
Sep 17 2024
• By Natasha Barrow
US FDA has greenlighted Senseonics’ Eversense 365 continuous glucose monitor, which must be replaced just once a year. Capable of being integrated with compatible insulin pumps as part of an automated insulin delivery system, the fully implantable device lasts 185 days longer than the Eversense E3 sensor and far outstrips competing CGMs, which last only for 10-14 days.